Found 39 matching trials
A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU
PHASE2This study is a phase II single-arm study designed to evaluate the efficacy...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)
PHASE1This is a single-center, phase I/IB study to identify the recommended phase...
Location
Moffitt Cancer Center
A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025)
PHASE2Researchers are looking for new ways to treat polycythemia vera (PV). Peopl...
Location
Multiple Locations
Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)
N/APolycythaemia vera (PV) is associated with a reduced quality of life, a hig...
Location
SC Ematologia, ASST Papa Giovanni XXIII
Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis
PHASE2To study the efficacy and safety of combination of Ro-Peg-interferon-α2b (R...
Location
Aalborg university hospital
Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
PHASE3This is a Phase 3 open-label, multicenter, single arm study designed to eva...
Location
Ehime University Hospital
Ropeginterferon for Treatment Free Remission
PHASE4Ropeginterferon is a long-acting next-generation mono-pegylated interferon ...
Location
Eulji University Hospital
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
PHASE3This is a phase 3 double-blind clinical trial arm to test Ropeginterferon a...
Status
Active Not Recruiting
Location
USC Norris Comprehensive Cancer Center
A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients
PHASE3The primary objective of this study is to assess the efficacy of ropeginter...
Status
Active Not Recruiting
Location
University Hospital Graz, Department of Internal Medicine, Clinical Department of Hematology
Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis
PHASE2In this open-label single arm phase 2 study, approximately 20 patients with...
Location
Department of Medicine, Queen Mary Hospital